Brief: Renalys Pharma To Be Acquired By Chugai Pharmaceutical
24/10/2025 09:06
Oct 24 (Reuters) - Renalys Pharma: RENALYS PHARMA TO BE ACQUIRED BY CHUGAI PHARMACEUTICAL RENALYS PHARMA: UPON EXECUTION OF SHARE ACQUISITION, CHUGAI WILL PAY RENALYS JPY 15.0 BILLION IN CASH RENALYS PHARMA:CHUGAI WILL PAY UP TO JPY 16.0 BILLION IN CASH CONTINGENT ON SPARSENTAN REGULATORY MILESTONES & NET SALES IN JAPAN, SOUTH KOREA & TAIWAN Source text: ID:nPnbhV3vVa Further company coverage: 4519.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)